Hepatitis C Support Group
Hepatitis C is a blood-borne viral disease which can cause liver inflammation, fibrosis, cirrhosis and liver cancer. The hepatitis C virus (HCV) is spread by blood-to-blood contact with an infected person's blood. Many people with HCV infection have no symptoms and are unaware of the need to seek treatment. Hepatitis C infects an estimated 150-200 million people worldwide.
BUT, it's cost prohibitive ($1,000 a pill/$84,00 for 12 days) and one of the major US drug ins cos is not going to pay for it...so most of here are WAITING.
Medvir's semeprivir/olysio is also approved for Gen 1, but doesn't seem to have as good a cure rate. They are currently enrolling an all oral trial: http://www.marketwatch.com/story/medivir-an-all-oral-phase-iia-study-combining-simeprevir-tmc647055-and-jnj56914845-in-hepatitis-c-patients-to-be-initiated-2013-12-12?reflink=MW_news_stmp
To find other clinical trials see: clinicaltrials.gove
I hope i told this right. So many drug names starting with "S" and ending with "vir' is quite confusing for my very feeble foggy brain. If I goofed on any of what i told you i hope someone will come along and correct me...
Read all you can here!
Goodnight and good luck.
I suppose I could get through 8 weeks but I have low tolerance for medicines.
Anyway, Sofosbuvir + Riba is approved for genotype 2 & 3. Genotypes 1 & 4 still need interferon.
However, the FDA approved sofosbuvir in combination with pegylated interferon alfa-2a (Pegasys or PegIntron) and ribavirin for 12 weeks for people with HCV genotypes 1 or 4. *****But it also said that sofosbuvir plus ribavirin for 24 weeks may be considered for genotype 1 patients who are ineligible for or unable to tolerate interferon.*****
http://www.hivandhepatitis.com/hcv-treatment/experimental-hcv-drugs/4438-fda-approves-sofosbuvir-sovaldi-for-hepatitis-c-genotypes-1-2-3-and-4
HC